Description
Erlocip is a medication used to treat non-small cell lung cancer. It contains the active substance Erlotinib Hydrochloride and is manufactured by Cipla Ltd. Erlocip is available in the form of 150 mg tablets and comes in a pack of 30 tablets.
Uses:
Erlocip is used to treat non-small cell lung cancer in individuals with certain genetic mutations that promote tumor growth. It works by blocking the activity of the epidermal growth factor receptor (EGFR) protein, which plays a key role in the growth and spread of cancer cells.
HOW TO USE:
Erlocip should be taken orally with or without food as directed by your doctor. The recommended dosage for Erlocip is one tablet of 150 mg per day. The duration of treatment varies depending on the individual’s response to treatment.
Storage Conditions:
Erlocip should be stored in a cool, dry place, away from direct sunlight and moisture. Keep the medication out of the reach of children and pets.
Mechanism of action:
Erlocip works by inhibiting the activity of the EGFR protein, which is highly expressed in non-small cell lung cancer cells. By blocking the activity of this protein, Erlocip suppresses the growth and spread of cancer cells, leading to a better prognosis and improved survival rates.
Precautions:
Erlocip should be used with caution in patients with liver or kidney disease. It should also be used with caution in pregnant women and breastfeeding mothers, as the use of Erlocip may harm the fetus or infant.
Contraindications:
Erlocip should not be used with certain medications, such as rifampin and phenytoin, due to the potential risk of serious adverse effects. It should also be used with caution in patients with a history of severe allergic reactions to medications.
Drug Interactions:
Erlocip may interact with other medications, such as antacids and proton pump inhibitors, that affect its absorption and efficacy. Inform your doctor about all medications you are currently taking to avoid any interactions.
Overdose:
Overdose of Erlocip can lead to nausea, vomiting, and diarrhea. Seek immediate medical attention in case of an overdose.
Side Effects:
Common side effects of Erlocip include rash, diarrhea, nausea, and fatigue. It may also cause a decrease in white blood cell count, leading to an increased risk of infection. However, most side effects of Erlocip are mild and resolve on their own over time. Contact your doctor immediately if you experience any severe side effects while taking Erlocip.
Reviews
There are no reviews yet.